Michael F Mahoney Boston Scientific Corp (BSX) insider trading activity

Michael F Mahoney is Chairman, President & CEO of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 1.52 Million shares of BSX, which is worth approximately $136 Million. The most recent transaction as insider was on Feb 18, 2022, when has been sold 7,233 shares (Common Stock) at a price of $42.55 per share, resulting in proceeds of $307,764. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.52M

9.12% 3M change

1.49% 12M change

Total Value Held $136 Million

Michael F Mahoney Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2022	SELL Payment of exercise price or tax liability	$307,764 $42.55 p/Share	7,233 Reduced 0.34%	2,113,559 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	-	16,307 Added 0.76%	2,120,792 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$348,251 $42.83 p/Share	8,131 Reduced 0.38%	2,104,485 Common Stock
Feb 17 2022	BUY Exercise of conversion of derivative security	-	18,333 Added 0.86%	2,112,616 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$360,266 $44.01 p/Share	8,186 Reduced 0.39%	2,094,283 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	-	18,457 Added 0.87%	2,102,469 Common Stock
Jan 01 2022	SELL Payment of exercise price or tax liability	$1,000,192 $42.48 p/Share	23,545 Reduced 1.12%	2,084,012 Common Stock
Jan 01 2022	BUY Exercise of conversion of derivative security	-	60,635 Added 2.8%	2,107,557 Common Stock
Nov 12 2021	SELL Bona fide gift	-	34,900 Reduced 1.68%	2,046,922 Common Stock
Nov 01 2021	SELL Open market or private sale	$8,654,858 $43.05 p/Share	201,042 Reduced 8.81%	2,081,822 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$1,375,127 $6.84 p/Share	201,042 Added 8.09%	2,282,864 Common Stock
Oct 04 2021	SELL Open market or private sale	$8,626,712 $42.91 p/Share	201,042 Reduced 8.81%	2,081,822 Common Stock
Oct 04 2021	BUY Exercise of conversion of derivative security	$1,375,127 $6.84 p/Share	201,042 Added 8.09%	2,282,864 Common Stock
Sep 07 2021	SELL Open market or private sale	$8,960,397 $44.57 p/Share	201,041 Reduced 8.81%	2,081,822 Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$1,375,120 $6.84 p/Share	201,041 Added 8.09%	2,282,863 Common Stock
Aug 02 2021	SELL Open market or private sale	$9,195,707 $45.74 p/Share	201,043 Reduced 8.81%	2,081,822 Common Stock
Aug 02 2021	BUY Exercise of conversion of derivative security	$1,375,134 $6.84 p/Share	201,043 Added 8.09%	2,282,865 Common Stock
Jul 06 2021	SELL Open market or private sale	$8,727,190 $43.41 p/Share	201,041 Reduced 8.81%	2,081,822 Common Stock
Jul 06 2021	BUY Exercise of conversion of derivative security	$1,375,120 $6.84 p/Share	201,041 Added 8.09%	2,282,863 Common Stock
May 14 2021	SELL Bona fide gift	-	34,965 Reduced 1.65%	2,081,822 Common Stock
Feb 28 2021	SELL Payment of exercise price or tax liability	$315,281 $38.78 p/Share	8,130 Reduced 0.38%	2,116,787 Common Stock
Feb 28 2021	BUY Exercise of conversion of derivative security	-	18,330 Added 0.86%	2,124,917 Common Stock
Feb 22 2021	SELL Payment of exercise price or tax liability	$402,937 $39.2 p/Share	10,279 Reduced 0.49%	2,106,587 Common Stock
Feb 22 2021	BUY Exercise of conversion of derivative security	-	23,175 Added 1.08%	2,116,866 Common Stock
Feb 21 2021	SELL Payment of exercise price or tax liability	$283,780 $38.03 p/Share	7,462 Reduced 0.36%	2,093,691 Common Stock

Also insider at

BAX

BAXTER INTERNATIONAL INC Healthcare

Director

CVS

CVS HEALTH Corp Healthcare

Director

MFM